Target intelligence / Profile preview

DNAJC8 pseudogene 2 (DNAJC8P2)

Target: DNAJC8P2
Molecular classification: Other (pseudogene)

Overview

DNAJC8P2 is a pseudogene related to the DNAJC8 gene. While DNAJC8 is a protein-coding member of the HSP40 (heat shock protein 40) family and has been implicated as a potential oncogene and therapeutic target in cancers (notably hepatocellular carcinoma), DNAJC8P2 itself does not encode a functional protein, is not considered a therapeutic target or biomarker, and has no demonstrated biological or disease-related role in current scientific literature[1][2].

Beyond the preview

Go deeper on DNAJC8 pseudogene 2 (DNAJC8P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNAJC8 pseudogene 2 (DNAJC8P2).

Explore the full profile